Variant report
| Variant | esv3348377 |
|---|---|
| Chromosome Location | chr2:35678788-35678956 |
| allele | n/a |
| Outlinks | Ensembl UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
Variant overlapped rSNPs/rCNVs (count:18 , 50 per page) page:
1
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs10166947 | chr2:35678807-35678808 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 2 | rs111785805 | chr2:35678858-35678859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs67456305 | chr2:35678859-35678860 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs62143285 | chr2:35678866-35678867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs62143286 | chr2:35678869-35678870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs13015392 | chr2:35678882-35678883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs190107319 | chr2:35678892-35678893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs533641079 | chr2:35678895-35678896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs553790584 | chr2:35678896-35678897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs182103287 | chr2:35678901-35678902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs200353792 | chr2:35678903-35678904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs201273061 | chr2:35678904-35678905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs200911679 | chr2:35678917-35678918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs59130524 | chr2:35678919-35678920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs187815330 | chr2:35678926-35678927 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs202145422 | chr2:35678931-35678932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs574961908 | chr2:35678936-35678937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs71451223 | chr2:35678952-35678953 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Variant related diseases (count:60)
| Disease | PMID | Source |
|---|---|---|
| Breast cancer | 17393978 | CNVD |
| Acute lymphoblastic leukemia | 21098271 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Lynch syndrome | 18415027 | CNVD |
| Basal cell lymphoma | 16317097 | CNVD |
| Diffuse large b-cell lymphoma | 16317097 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Diffuse large b-cell lymphoma | 18287131 | CNVD |
| Ovarian neoplasms | 16753589 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Neuroblastoma | 17533364 | CNVD |
| Neuroblastoma | 18923191 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Adrenal tumor | 17535989 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Basal cell lymphoma | 17053054 | CNVD |
| Medulloblastoma | 17522785 | CNVD |
| Cancer | 23418310 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Ependymoma | 16718352 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| Bladder cancer | 21909424 | CNVD |
| Thoracic aortic aneurysm | 21092924 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Intellectual disability | 22102821 | CNVD |
| Cancer | 20164919 | CNVD |
| Hodgkin''s lymphoma | 18641027 | CNVD |
| Autism | 22495311 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Follicular lymphoma | 20505157 | CNVD |
| Autism | 17483303 | CNVD |
| Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
| Myofibroblastic sarcoma | 19369631 | CNVD |
| Esophageal adenocarcinoma | 18519675 | CNVD |
| Medulloblastoma | 20607354 | CNVD |
| Leukemia | 18628472 | CNVD |
| Autism | 19521722 | CNVD |
| Autism | 18522746 | CNVD |
| Breast cancer | 21364760 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Non-small cell lung cancer | 18927303 | CNVD |
| Hereditary gingival fibromatosis | 19633868 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Breast cancer | 21045282 | CNVD |
| Prostate cancer | 21965145 | CNVD |
| Breast cancer | 16397240 | CNVD |
| Acute lymphoblastic leukemia | 21390130 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Neuroblastoma | 21508638 | CNVD |
| Neurodevelopmental disorder | 22521361 | CNVD |
| Neurocytoma | 17123091 | CNVD |
| Autism | 22495309 | CNVD |
| Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr2:35668600-35680200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
| 2 | chr2:35678600-35679400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
